Director, Regional Commercial Strategy, ImmunoDerm

Lead the commercial strategy, performance, competitiveness, and growth of the APAC ImmunoDerm portfolio, including TREMFYA, ICOTYDE, and future pipeline assets such as Atopic Dermatitis .

Accountable for driving portfolio growth, launch excellence, market leadership, and pipeline readiness across APAC while shaping regional priorities and influencing Global Immunology strategy.

Key Outcome: Deliver sustainable growth, successful launches, and long‑term market leadership for the ImmunoDerm franchise.

• Lead APAC strategy across TREMFYA, ICOTYDE, and pipeline assets.
• Drive portfolio prioritization and investment allocation.
• Lead market shaping and launch readiness for Atopic Dermatitis and future indications.
• Embed data, analytics, and insights into decision making.

• Accelerate TREMFYA growth and market leadership.
...